HRP20160706T1 - Injektabilna prezasićena otopina acetaminofena za spinalnu primjenu - Google Patents

Injektabilna prezasićena otopina acetaminofena za spinalnu primjenu Download PDF

Info

Publication number
HRP20160706T1
HRP20160706T1 HRP20160706TT HRP20160706T HRP20160706T1 HR P20160706 T1 HRP20160706 T1 HR P20160706T1 HR P20160706T T HRP20160706T T HR P20160706TT HR P20160706 T HRP20160706 T HR P20160706T HR P20160706 T1 HRP20160706 T1 HR P20160706T1
Authority
HR
Croatia
Prior art keywords
acetaminophen
aqueous solution
supersaturated
use according
local anesthetic
Prior art date
Application number
HRP20160706TT
Other languages
English (en)
Croatian (hr)
Inventor
Augusto Mitidieri
Elisabetta Donati
Nicola CARONZOLO
Original Assignee
Sintetica S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46690603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20160706(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sintetica S.A. filed Critical Sintetica S.A.
Publication of HRP20160706T1 publication Critical patent/HRP20160706T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20160706TT 2012-06-29 2013-06-27 Injektabilna prezasićena otopina acetaminofena za spinalnu primjenu HRP20160706T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001154A ITMI20121154A1 (it) 2012-06-29 2012-06-29 Soluzione iniettabile di acetaminofene per la somministrazione spinale
PCT/IB2013/055277 WO2014002042A1 (en) 2012-06-29 2013-06-27 Injectable supersaturated acetaminophen solution for spinal administration
EP13765450.5A EP2874602B1 (en) 2012-06-29 2013-06-27 Injectable supersaturated acetaminophen solution for spinal administration

Publications (1)

Publication Number Publication Date
HRP20160706T1 true HRP20160706T1 (hr) 2016-08-12

Family

ID=46690603

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20160706TT HRP20160706T1 (hr) 2012-06-29 2013-06-27 Injektabilna prezasićena otopina acetaminofena za spinalnu primjenu

Country Status (44)

Country Link
US (2) US11344517B2 (OSRAM)
EP (1) EP2874602B1 (OSRAM)
JP (1) JP5876620B2 (OSRAM)
KR (1) KR102118227B1 (OSRAM)
CN (1) CN104487051B (OSRAM)
AP (1) AP2014008152A0 (OSRAM)
AR (1) AR091633A1 (OSRAM)
AU (1) AU2013282753B2 (OSRAM)
BR (1) BR112014032818B1 (OSRAM)
CA (1) CA2876801C (OSRAM)
CL (1) CL2014003536A1 (OSRAM)
CO (1) CO7240357A2 (OSRAM)
CR (1) CR20150036A (OSRAM)
CU (1) CU20140150A7 (OSRAM)
CY (1) CY1117691T1 (OSRAM)
DK (1) DK2874602T3 (OSRAM)
DO (1) DOP2014000302A (OSRAM)
EA (1) EA028909B1 (OSRAM)
EC (1) ECSP15000500A (OSRAM)
ES (1) ES2578012T3 (OSRAM)
GE (1) GEP201706689B (OSRAM)
HR (1) HRP20160706T1 (OSRAM)
HU (1) HUE029431T2 (OSRAM)
IL (1) IL236423A (OSRAM)
IT (1) ITMI20121154A1 (OSRAM)
MA (1) MA37811B1 (OSRAM)
MD (1) MD4537C1 (OSRAM)
ME (1) ME02431B (OSRAM)
MX (1) MX369264B (OSRAM)
MY (1) MY169251A (OSRAM)
NI (1) NI201400147A (OSRAM)
NZ (1) NZ703829A (OSRAM)
PE (1) PE20150331A1 (OSRAM)
PH (1) PH12015500178B1 (OSRAM)
PL (1) PL2874602T3 (OSRAM)
PT (1) PT2874602T (OSRAM)
RS (1) RS54844B1 (OSRAM)
SG (2) SG11201408479WA (OSRAM)
SI (1) SI2874602T1 (OSRAM)
SM (1) SMT201600248B (OSRAM)
TN (1) TN2014000526A1 (OSRAM)
UA (1) UA117101C2 (OSRAM)
WO (1) WO2014002042A1 (OSRAM)
ZA (1) ZA201409478B (OSRAM)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766321A (en) * 1993-04-14 1998-06-16 Nippon Sanso Corporation Apparatus for reducing dissolved oxygen
US6171298B1 (en) * 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) * 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
US20050203175A1 (en) * 2001-12-18 2005-09-15 Ioulia Tseti Parenteral composition of paracetamol
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
DE102005037653A1 (de) * 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
WO2008009756A1 (es) * 2006-07-18 2008-01-24 Genfarma Laboratorio S.L. Formulación líquida inyectable de paracetamol
CN101015542A (zh) * 2007-02-13 2007-08-15 天津生机集团有限公司 家畜用复方对乙酰氨基酚注射液及其制备方法
MD3528G2 (ro) * 2007-09-28 2008-11-30 Сергей ШАНДРУ Metodă de anestezie spinală continuă la pacienţii în etate
WO2009064928A1 (en) * 2007-11-13 2009-05-22 Cadence Pharmaceuticals Reduced dose intravenous acetaminophen
EP2307056B1 (en) 2008-01-17 2021-12-15 Pharmis Biofarmacêutica, LDA Stabilized aqueous formulation containing paracetamol
WO2009143558A1 (en) 2008-05-26 2009-12-03 Silphion Pty Limited Injectable formulations
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
JP2013006770A (ja) 2009-10-09 2013-01-10 Ssp Co Ltd アセトアミノフェン含有経口液剤
AU2011273064B2 (en) * 2010-06-30 2014-01-09 Troikaa Pharmaceuticals Limited Pharmaceutical compositions comprising paracetamol and process for preparing the same

Also Published As

Publication number Publication date
WO2014002042A1 (en) 2014-01-03
RS54844B1 (sr) 2016-10-31
AU2013282753B2 (en) 2017-03-02
AU2013282753A1 (en) 2015-02-05
NZ703829A (en) 2016-06-24
CN104487051B (zh) 2017-12-12
MA37811A1 (fr) 2016-10-31
DOP2014000302A (es) 2015-03-15
EP2874602A1 (en) 2015-05-27
MY169251A (en) 2019-03-19
PL2874602T3 (pl) 2016-10-31
MD4537B1 (ro) 2017-12-31
IL236423A (en) 2017-07-31
TN2014000526A1 (en) 2016-03-30
SI2874602T1 (sl) 2016-09-30
BR112014032818B1 (pt) 2022-06-14
ZA201409478B (en) 2016-01-27
EA201500065A1 (ru) 2015-10-30
US20150148379A1 (en) 2015-05-28
US20160128955A1 (en) 2016-05-12
MX369264B (es) 2019-11-04
US11344517B2 (en) 2022-05-31
EP2874602B1 (en) 2016-03-30
ECSP15000500A (es) 2015-11-30
CL2014003536A1 (es) 2015-05-08
MD20140138A2 (ro) 2015-06-30
AP2014008152A0 (en) 2014-12-31
GEP201706689B (en) 2017-06-26
CR20150036A (es) 2015-03-13
CN104487051A (zh) 2015-04-01
JP5876620B2 (ja) 2016-03-02
CA2876801C (en) 2020-11-03
CO7240357A2 (es) 2015-04-17
ITMI20121154A1 (it) 2013-12-30
AR091633A1 (es) 2015-02-18
CY1117691T1 (el) 2017-05-17
NI201400147A (es) 2015-04-13
IL236423A0 (en) 2015-02-26
SMT201600248B (it) 2016-08-31
BR112014032818A2 (pt) 2017-06-27
EA028909B1 (ru) 2018-01-31
SG11201408479WA (en) 2015-01-29
HUE029431T2 (en) 2017-03-28
SG10201704482YA (en) 2017-07-28
PH12015500178A1 (en) 2015-04-06
MD4537C1 (ro) 2018-07-31
CA2876801A1 (en) 2014-01-03
MA37811B1 (fr) 2017-07-31
PT2874602T (pt) 2016-07-13
JP2015522004A (ja) 2015-08-03
CU20140150A7 (es) 2015-10-27
KR20150027160A (ko) 2015-03-11
DK2874602T3 (en) 2016-07-04
UA117101C2 (uk) 2018-06-25
PH12015500178B1 (en) 2021-08-04
PE20150331A1 (es) 2015-03-07
MX2014015402A (es) 2015-06-17
KR102118227B1 (ko) 2020-06-03
ME02431B (me) 2016-09-20
ES2578012T3 (es) 2016-07-20

Similar Documents

Publication Publication Date Title
AR085128A1 (es) Composicion de acido hialuronico
MX382569B (es) Compuesto de carboxamida, sulfonamida y amina para trastornos metabolicos.
JP2014527964A5 (OSRAM)
BR112014005358A2 (pt) composição para alívio da dor, compreendendo um agonista seletivo de trpv1, e a sua fabricação e utilização
JP2017178948A5 (OSRAM)
UA111834C2 (uk) Лікарська форма
SMT201400081B (it) Composizioni farmaceutiche di clevidipina e metodiper produrre concentrazioni di questa con un bass o livello di impurezze
EA201071231A1 (ru) Карбоксамидные соединения для лечения метаболических растройств
EP2307056A4 (en) STABILIZED AQUEOUS FORMULATION WITH PARACETAMOL
BR112016007522A2 (pt) painéis de gesso usando uma proporção elevada de água-estuque
JO3557B1 (ar) صيغة توليفة صيدلانية تشتمل على أملوديبين ولوسارتان وروسوفاستاتين
HRP20180079T1 (hr) Transdermalni sustav za isporuku
EA201170979A1 (ru) Карбоксамидные соединения и способы их применения
AR078856A1 (es) Composiciones locales de emulsion anestesica y metodos para la fabricacion y utilizacion de las mismas
MX2014005405A (es) Una composicion de limpieza personal.
BRPI0719772A2 (pt) Compostos, composições fungicidas para combater fungos nocivos fitopatogênicos, agente, método para combater fungos nocivos fitopatogênicos, semente, uso dos compostos, e, composição farmacêutica.
HRP20160706T1 (hr) Injektabilna prezasićena otopina acetaminofena za spinalnu primjenu
EP3900711A4 (en) STABILIZED DONEPEZIL CONTAINING TRANSDERMAL ABSORPTION PREPARATION
JP2020519593A5 (OSRAM)
IN2014DE00467A (OSRAM)
EP3491937A4 (en) LIQUID SEASONING AGENT WITH SOLID INGREDIENTS
EP3386501C0 (de) Analgetische zusammensetzungen mit nanocarriern und ihre verwendung
TH1401003169B (th) ส่วนประกอบที่มี 4-ออกโซ-2,2,6,6-เตตระเมทิลพิเพอริดีน-1-ออกซิลที่เสถียรรวมอยู่ ส่วนประกอบสารยับยั้งโพลิเมอไรเซชันของสารประกอบไวนิล และวิธียั้บยั้ง โพลิเมอไรเซชันของสารประกอบไวนิลโดยใช้ส่วนประกอบนี้
RU2020112204A (ru) Анестетические композиции с замедленным высвобождением и способы их получения
Zeyin et al. Research of corrosion inhibition and foaming compound agent for acidic gas reservoir.